ecteinascidins (PharmaMar/NCI)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameecteinascidins (PharmaMar/NCI)
Drug Alias NameET-729ET-745NSC-638718ET-583ET-596 +[11
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionDNA modulators
TargetsDNA
Therapy Area/IndicationsLung NeoplasmsBreast NeoplasmsMelanoma +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsLung NeoplasmsBreast NeoplasmsMelanoma +[4

Other Information

ATC CodeN/A
Related LinksN/A